6
Views
17
CrossRef citations to date
0
Altmetric
Article

Treatment of Urinary Tract Infection with Pivampicillin: A New Ampicillin Derivative

, , &
Pages 59-65 | Published online: 02 Jan 2015

References

  • . Brumfitt, W., Percival, A. & Carter, M. J.: Treatment of urinary tract infection with ampicillin. Lancet 1: 131, 1962.
  • . Brumfitt, W. & Percival, A.: Laboratory control of antibiotic therapy in urinary tract infection. Ann NY Acad Sci 145: 329, 1967.
  • . von Daehne, W., Frederiksen, E., Gundersen, E., Lund, P., Mørch, P., Petersen, H. J., Roholt, K., Tybring, L. & Godtfredsen, W. O.: Acyloxymethyl esters of ampicillin. J Med Chem 13: 607, 1970.
  • . Foltz, E. L., West, J. W., Breslow, I. H. & Wallick, H.: Clinical pharmacology of pivampicillin. Antimicrob Agents Chemother, p. 442, 1970.
  • . Frederiksen, E., Godtfredsen, W. O., Nielsen, B. & Roholt, K.: Pivampicillinklorid: et nyt bredspektret antibiotikum til oral anvendelse. Nord Med 86: 1376, 1971.
  • . Jordan, M. C., de Maine, J. B. & Kirby, W. M. M.: Clinical pharmacology of pivampicillin as compared with ampicillin. Antimicrob Agents Chemother, p. 438, 1970.
  • . Kirby, W. M. M. & Kind, A. C.: Clinical pharmacology of ampicillin and hetacillin. Ann NY Acad Sci 145: 291, 1967.
  • . Knudsen, E. T., Rolinson, G. N. & Stevens, S.: Absorption and excretion of “Penbritin”. Br Med J 2: 198, 1961.
  • . Nilsson, L. B.: Långtidsbehandling med pivampicillinklorid. Nord Med 86: 1381, 1971.
  • . Percival, A., Brumfitt, W. & de Louvois, J.: Serum-antibody levels as an indication of clinically apparent pyelonephritis. Lancet 2: 1027, 1964.
  • . Reeves, D. S. & Brumfitt, W.: Localization of urinary tract infection. In: Urinary tract infection, p. 53 (ed. F. O'Grady & W. Brumfitt). Oxford University Press, London 1968.
  • . Winberg, J., Andersen, H. J., Hanson, L. Å. & Lincoln, K.: Studies of urinary tract infection in infancy and childhood. Br Med J 2: 524, 1963.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.